<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ERI-T-MOH-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Tuberculosis - Eritrea (01-Oct-2011-13-Mar-2014)</narrative>
    </title>
    <description type="1">
      <narrative>Eritrea, Tuberculosis, Ministry of Health of the State of Eritrea</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <other-identifier ref="ERI-T-MOHP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2011-10-01" />
    <activity-date type="2" iso-date="2011-10-01" />
    <activity-date type="3" iso-date="2014-03-13" />
    <activity-date type="4" iso-date="2014-03-13" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Job Muriuki</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>job.muriuki@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ER" percentage="100">
      <narrative>Eritrea</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="0d5b4a78-80c4-4d67-b790-c1099d4fecef">
      <transaction-type code="3" />
      <transaction-date iso-date="2011-12-28" />
      <value currency="USD" value-date="2011-12-28">2200964.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6f9e6370-2c4a-4cf1-9dd8-8e7b5f5957c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2012-10-26" />
      <value currency="USD" value-date="2012-10-26">2307464.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cdb7b85d-a2d4-40f4-afd2-60dd482ddb98">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-04-25" />
      <value currency="USD" value-date="2013-04-25">854771.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f6327da8-4944-45ce-b6be-0cf3a6464fed">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-04-25" />
      <value currency="USD" value-date="2013-04-25">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="39db5199-13b7-475b-a83c-7c61f11d2842">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-07-30" />
      <value currency="USD" value-date="2013-07-30">614792.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d1602613-313d-47f0-98d0-a65d26201fef">
      <transaction-type code="3" />
      <transaction-date iso-date="2013-10-10" />
      <value currency="USD" value-date="2013-10-10">535954.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bebcb0a4-fd19-465d-a8e1-89f193be483d">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-01-16" />
      <value currency="USD" value-date="2014-01-16">6563945.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ERI-T-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ERI-T-MOH-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Expansion of stop TB strategy; reaching the hard to reach and preventing missed opportunities - Eritrea (01-Jan-2014-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>The fight against Tuberculosis (TB) has been and still remains a major health intervention in Eritrea’s goal for a healthy population. Eritrea has a countrywide DOTS coverage of 100% and treatment success rate of 85% surveys ; however, the country has not achieved the WHO stop TB targets of case detection rate of 70%. This Program is a consolidation of Round 10 and Round 6 TB grants. The Round 10 seeks to improve access to TB diagnosis and monitoring. The proposal is consistent with Eritrea’s National Strategic Plan and is designed to fill gaps and overcome weaknesses in the response to Eritrea’s TB epidemic, while complementing the Round 6 program as well as other investments. The goal of the Program is to significantly reduce the burden and the transmission of tuberculosis in line with the Millennium Development Goals and the STOP TB partnership targets so that TB no longer remains a public health problem in Eritrea. The Program targets TB suspects &amp;amp; TB Patients; prisoners, prison staff and their family members; general population; and health promoters and health staff.</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Reduce incidence of TB by 50% in 2025 compared to 2015 levels. Objectives: To achieve and maintain atleast 75% treatment success rate among confirmed RR/MDR- TB cases by 2017; To increase case notification of all forms of TB (new and relapse) by average 5% per annum to reach 2806 by 2017 and to maintain atleast 90% treatment success rate among all new TB cases; To reduce death rate among HIV infected TB patients from 16% at the end of 2014 to 7% by 2017 (3% reduction every year).</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <other-identifier ref="ERI-T-MOHP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2014-01-01" />
    <activity-date type="2" iso-date="2014-01-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Job Muriuki</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>job.muriuki@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ER" percentage="100">
      <narrative>Eritrea</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="71b17981-8224-4cd0-a05b-6f16562db711">
      <transaction-type code="2" />
      <transaction-date iso-date="2014-04-11" />
      <value currency="USD" value-date="2014-04-11">5262087.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="187e3622-fe44-40eb-9b9d-f7bf26855f06">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-04-14" />
      <value currency="USD" value-date="2014-04-14">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2e2e4180-e0c4-4c75-8807-0a570414f1be">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-04-14" />
      <value currency="USD" value-date="2014-04-14">1854607.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2ce39577-5433-4a7d-8a72-40b5800f911d">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-07-01" />
      <value currency="USD" value-date="2014-07-01">1383627.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="98ca79e0-070e-4841-a9f9-696afbfce801">
      <transaction-type code="3" />
      <transaction-date iso-date="2014-11-27" />
      <value currency="USD" value-date="2014-11-27">1998853.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0141b32b-cd06-4995-9197-1d3958e2d468">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-04-29" />
      <value currency="USD" value-date="2015-04-29">25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7a6d8458-91d9-48bf-b5d0-3becece0018e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-05-01" />
      <value currency="USD" value-date="2015-05-01">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bc9a6113-18d2-47d0-9ecb-a5425d18e6d9">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-08-03" />
      <value currency="USD" value-date="2015-08-03">1112617.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3b2a3d79-6199-442d-8947-c77e26a775a0">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-08-04" />
      <value currency="USD" value-date="2015-08-04">592735.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="05ba6a54-473c-4d72-a10a-a9aa63cbbeee">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-02-23" />
      <value currency="USD" value-date="2016-02-23">519882.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ca29aec-984c-4247-8cbd-481ab6699030">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-05-26" />
      <value currency="USD" value-date="2016-05-26">2249122.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6660ce82-e8d6-4566-b297-85d596f6bc46">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-05-27" />
      <value currency="USD" value-date="2016-05-27">501866.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6a66aa3-4e48-48a8-bd4b-3892ff5ebe13">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-05-27" />
      <value currency="USD" value-date="2016-05-27">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b7bff856-f685-4df6-996b-509ed1e3f2e4">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-10-13" />
      <value currency="USD" value-date="2016-10-13">792252.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="79a0b5fa-d900-47d2-b35f-0bfb4f8f20ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-03-16" />
      <value currency="USD" value-date="2017-03-16">401525.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8726b77d-d082-42cd-ae65-844ab3d736f7">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">-528479.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a9be34f5-1559-48fd-bb51-54a97ce75be7">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">534001.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bf0b3be8-5388-410f-9374-067253282aef">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-28" />
      <value currency="USD" value-date="2017-07-28">296154.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0563391b-2b51-4779-942c-df10829ff878">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-08" />
      <value currency="USD" value-date="2017-11-08">302216.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d8964ff4-feb4-44c5-b486-cc611791303f">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-08" />
      <value currency="USD" value-date="2017-11-08">-237847.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3cb4dc23-5561-4a15-b780-529cd1660500">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-10" />
      <value currency="USD" value-date="2017-11-10">302216.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b6b8a29a-db6b-4742-822e-9e8de8f59b0c">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="01924577-1818-4eb3-93fe-18a86245d96f">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="47a7c50b-597f-4c8b-aa26-9785494f9274">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-17" />
      <value currency="USD" value-date="2018-05-17">73384.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="00dfb18c-613d-42c2-9dad-47d8a9de1169">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-18" />
      <value currency="USD" value-date="2018-05-18">73384.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ERI-T-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ERI-T-MOH-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Expansion of Stop TB Strategy; Reaching the Hard to Reach and Preventing Missed Opportunities - Eritrea (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Eritrea, Tuberculosis, Ministry of Health of the State of Eritrea</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduc by 50% (30/100,000 population) the incidence of TB by 2021 compare to 2015. Objectives: To increase case notification rate of all forms of TB (new and relapse) by average 4% per annum from 67% in 2016 to reach approximately 85% by 2021; To maintain achievements in treatment success rate among all new TB cases at 90% or above by 2021; To increase MDR-TB cases detected and enrolled for treatment from 32% of the estimated total cases in 2016 to 70% in 2021; To increase treatment success rate among confirmed RR/MDR-TB from 67% in 2015 to achieve and maintain at least 75% by 2021; To reduce mortality among HIV infected TB patients from 9.8% in 2016 to 5% by 2021.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <other-identifier ref="ERI-T-MOHP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Job Muriuki</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>job.muriuki@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ER" percentage="100">
      <narrative>Eritrea</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="84.17">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="15.83">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="8.39">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="3">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="0.54">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="1.75">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="1.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="0.69">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="ad843466-bf87-44ef-9b83-217a8cfb22d0" percentage="0.35">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National costed supply chain master plan, and implementation</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="11.39">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="5e616c4b-3854-4008-8caa-4cb786ae6fe1" percentage="0.65">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="43569924-d9cb-4e7a-90e7-975fd08c02de" percentage="3.98">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="10.33">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="34.39">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="13.98">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="2.61">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="1.27">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="5.24">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="13c1e439-070b-4238-9903-7972703a027e" percentage="0.11">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="0.22">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">1364844.83</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">1404488.50</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">1597302.94</value>
    </budget>
    <capital-spend percentage="21.87" />
    <transaction ref="b038e38d-48fb-4ee2-a43c-3a2b98084a8d">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-01-30" />
      <value currency="USD" value-date="2018-01-30">2353224.88</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0d7ef51f-871f-404e-8d49-ebf11e53f72c">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-02-01" />
      <value currency="USD" value-date="2018-02-01">926639.83</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9133d983-2760-4155-a89e-c629581bc601">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-07" />
      <value currency="USD" value-date="2018-05-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f63c1147-03c5-4aae-8dc3-bd5f6b6a7d71">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">644826.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="90995b70-55d9-45cf-b09b-50f32a54c880">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-05" />
      <value currency="USD" value-date="2018-10-05">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e67f8b95-beb3-418e-b436-391dad5fd6c2">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-18" />
      <value currency="USD" value-date="2018-10-18">222661.35</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ac569a8d-9748-4150-a6c6-2a42225ea4f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-13" />
      <value currency="USD" value-date="2018-12-13">69958.07</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="58901583-b475-40f7-9ea6-7b4bbc1b3f3c">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-25" />
      <value currency="USD" value-date="2019-01-25">98100.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b708b927-8797-458a-a7a4-f921d957413b">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-07" />
      <value currency="USD" value-date="2019-05-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ad3d5af0-86d2-4169-aa97-7f908d119876">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-20" />
      <value currency="USD" value-date="2019-05-20">-391039.63</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cdf83e6e-1e4f-49a6-8955-ee1551d10f1c">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-20" />
      <value currency="USD" value-date="2019-05-20">1920684.62</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8eee915d-0c50-41f3-b902-122cc11f3159">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-21" />
      <value currency="USD" value-date="2019-05-21">14858.16</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="15751692-a394-4cbe-915b-0232a45b3e97">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-05-23" />
      <value currency="USD" value-date="2019-05-23">83806.06</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1b04c121-6371-487c-81da-8af67bd6dc9f">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-04" />
      <value currency="USD" value-date="2019-06-04">215178.46</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1b1aa9e0-d8fe-450d-ae72-1aa32c4806b6">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-08-08" />
      <value currency="USD" value-date="2019-08-08">715248.01</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="662e14dc-e0e6-4112-a982-19b4d7b4225e">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-10" />
      <value currency="USD" value-date="2019-10-10">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8c18bc0d-4923-4ffd-966f-d3b3dd6cde29">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-05" />
      <value currency="USD" value-date="2019-12-05">114438.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c25501a7-6dc0-400b-a0fc-3f04eaaffc3c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-04" />
      <value currency="USD" value-date="2020-02-04">609389.93</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2f964bf4-ad73-451d-841e-da4d4a55e246">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-11" />
      <value currency="USD" value-date="2020-02-11">6897.43</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="261f7194-4cfe-409a-87e8-e704961581f7">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-20" />
      <value currency="USD" value-date="2020-02-20">31246.95</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="410ebdbc-d014-48b8-bddd-9f35d0b82883">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-08" />
      <value currency="USD" value-date="2020-05-08">25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5643a5cf-674b-4b6e-948f-5b05003b5313">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-21" />
      <value currency="USD" value-date="2020-05-21">-129621.62</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5814513c-7444-4534-9703-2122402ba240">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-21" />
      <value currency="USD" value-date="2020-05-21">387081.54</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="49b43bc5-a183-46f2-ac3a-c08fa4d15aed">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-26" />
      <value currency="USD" value-date="2020-05-26">117718.70</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dadc5b15-fd2e-4288-b2ed-3db9872e57ab">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-16" />
      <value currency="USD" value-date="2020-06-16">87777.68</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2f97fbd6-1648-473d-b1a3-93d23b81fd54">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-24" />
      <value currency="USD" value-date="2020-06-24">66094.74</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ddb683aa-39f9-422e-8791-c56777f63332">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-02" />
      <value currency="USD" value-date="2020-09-02">84552.30</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bc4996c6-12bb-4e5f-b4fe-cc4e0eb02a04">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-06-02" />
      <value currency="USD" value-date="2021-06-02">34841.93</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="82510979-6a20-4228-a193-45c720fff187">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-06-21" />
      <value currency="USD" value-date="2021-06-21">206.21</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="45926cf9-0e43-47ef-a154-1f75b5b1f6dd">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-28" />
      <value currency="USD" value-date="2021-06-28">-206.21</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e9f2accd-c3e1-4f34-a5b0-7906bc222823">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-29" />
      <value currency="USD" value-date="2021-06-29">-34841.93</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5f8e524a-5d74-4f56-a110-f67207d511ec">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-09-01" />
      <value currency="USD" value-date="2021-09-01">3197.12</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f7323e82-e800-473c-81ac-f60e531fecf9">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-30" />
      <value currency="USD" value-date="2021-09-30">-3197.12</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e2888a97-412b-4d10-ae33-e49341211c71">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-01" />
      <value currency="USD" value-date="2021-12-01">610.21</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e76d5aa7-5d47-4587-854b-7d9ed3472e5c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-03" />
      <value currency="USD" value-date="2021-12-03">-610.21</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5f9a085-3479-4b23-b5cf-2acf37224ca5">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-04-20" />
      <value currency="USD" value-date="2022-04-20">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8ca20f4a-362d-4d18-b267-ae82b11093f5">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-04" />
      <value currency="USD" value-date="2022-05-04">-30938.12</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ERI-T-MOHP03-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">966799.91</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP03, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ERI-T-MOHP03-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">1249027.37</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP03, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ERI-T-MOHP03-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">1431622.40</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP03, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ERI-T-MOHP03-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">424798.19</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP03, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ERI-T-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 10.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 10.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 10.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 14.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 14.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 14.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5; Denominator: 20; Percentage: 25%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11; Denominator: 30; Percentage: 36.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 10; Denominator: 11; Percentage: 90.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4; Denominator: 11; Percentage: 36.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 7; Denominator: 11; Percentage: 63.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6; Denominator: 6; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4; Denominator: 6; Percentage: 66.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2; Denominator: 6; Percentage: 33.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 10.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 10.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 10.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 10.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 14.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 14.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 14.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 14.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4; Denominator: 20; Percentage: 20%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11; Denominator: 30; Percentage: 36.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 10; Denominator: 11; Percentage: 90.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 11; Percentage: 9.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4; Denominator: 11; Percentage: 36.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 7; Denominator: 11; Percentage: 63.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6; Denominator: 6; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4; Denominator: 6; Percentage: 66.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2; Denominator: 6; Percentage: 33.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 0; Denominator: 6; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 18.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 16; Denominator: 18; Percentage: 88.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 18; Percentage: 11.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 7; Denominator: 18; Percentage: 38.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 11; Denominator: 18; Percentage: 61.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 10.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of facility reports received over the reports expected during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of facility reports received over the reports expected during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="100">
          <comment>
            <narrative>Numerator: 144; Denominator: 144.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 144; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 144; Denominator: 144.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 144; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 146; Denominator: 146.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 144; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 144; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 144; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 144; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 144; Denominator: 144.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 2246.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1859.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1859.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1859.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1859.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 356.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 356.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 356.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 356.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 841.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 841.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 841.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 841.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1033.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1033.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1033.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1033.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1182.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1182.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1182.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1182.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2078.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2078.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2078.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2078.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 5.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 5.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 5.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 5.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 132.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 132.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 132.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 132.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1386.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 947.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1386.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 925; Denominator: 1386; Percentage: 66.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1532.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 966; Denominator: 1532; Percentage: 63%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 852; Denominator: 966; Percentage: 88.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 114; Denominator: 966; Percentage: 11.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 472; Denominator: 966; Percentage: 48.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 439; Denominator: 966; Percentage: 45.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 527; Denominator: 966; Percentage: 54.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 919; Denominator: 964; Percentage: 95.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 2; Denominator: 966; Percentage: 0.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 45; Denominator: 964; Percentage: 4.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1533.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 862.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 746; Denominator: 862; Percentage: 86.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 116; Denominator: 862; Percentage: 13.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 421; Denominator: 862; Percentage: 48.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 383; Denominator: 862; Percentage: 44.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 479; Denominator: 862; Percentage: 55.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 834; Denominator: 861; Percentage: 96.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 1; Denominator: 861; Percentage: 0.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 27; Denominator: 861; Percentage: 3.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1691.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 720.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 626; Denominator: 720; Percentage: 86.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 94; Denominator: 720; Percentage: 13.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 342; Denominator: 720; Percentage: 47.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 329; Denominator: 720; Percentage: 45.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 391; Denominator: 720; Percentage: 54.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 686; Denominator: 720; Percentage: 95.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 0; Denominator: 720; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 34; Denominator: 720; Percentage: 4.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1691.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 875.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 768.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 107.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 421.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 390.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 485.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 845.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="94">
          <comment>
            <narrative>Numerator: 63; Denominator: 67.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="95.5">
            <comment>
              <narrative>Numerator: 64; Denominator: 67.</narrative>
            </comment>
          </target>
          <actual value="98.6">
            <comment>
              <narrative>Numerator: 71; Denominator: 72.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="95.5">
            <comment>
              <narrative>Numerator: 64; Denominator: 67.</narrative>
            </comment>
          </target>
          <actual value="98.6">
            <comment>
              <narrative>Numerator: 71; Denominator: 72.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="97.2">
            <comment>
              <narrative>Numerator: 70; Denominator: 72.</narrative>
            </comment>
          </target>
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 74; Denominator: 75.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="97.2">
            <comment>
              <narrative>Numerator: 70; Denominator: 72.</narrative>
            </comment>
          </target>
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 74; Denominator: 75.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 75; Denominator: 75.</narrative>
            </comment>
          </target>
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 74; Denominator: 75.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 75; Denominator: 75.</narrative>
            </comment>
          </target>
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 74; Denominator: 75.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="100">
          <comment>
            <narrative>Numerator: 72; Denominator: 72.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 72; Denominator: 72.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 72; Denominator: 72.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 72; Denominator: 72.</narrative>
            </comment>
          </target>
          <actual value="94.5">
            <comment>
              <narrative>Numerator: 69; Denominator: 73.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 72; Denominator: 72.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 76; Denominator: 76.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 72; Denominator: 72.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 76; Denominator: 76.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 72; Denominator: 72.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 76; Denominator: 76.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 72; Denominator: 72.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 72; Denominator: 72.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="89.8">
          <comment>
            <narrative>Numerator: 1881; Denominator: 2095.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 1125; Denominator: 1250.</narrative>
            </comment>
          </target>
          <actual value="92.2">
            <comment>
              <narrative>Numerator: 993; Denominator: 1077.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 1125; Denominator: 1250.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 890; Denominator: 959.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 1248; Denominator: 1386.</narrative>
            </comment>
          </target>
          <actual value="92.3">
            <comment>
              <narrative>Numerator: 869; Denominator: 942.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 1248; Denominator: 1386.</narrative>
            </comment>
          </target>
          <actual value="93.8">
            <comment>
              <narrative>Numerator: 868; Denominator: 925.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 1380; Denominator: 1533.</narrative>
            </comment>
          </target>
          <actual value="93.4">
            <comment>
              <narrative>Numerator: 893; Denominator: 956.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 1380; Denominator: 1533.</narrative>
            </comment>
          </target>
          <actual value="92.3">
            <comment>
              <narrative>Numerator: 796; Denominator: 862.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="97">
          <comment>
            <narrative>Numerator: 128; Denominator: 132.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="97">
            <comment>
              <narrative>Numerator: 64; Denominator: 66.</narrative>
            </comment>
          </target>
          <actual value="96.1">
            <comment>
              <narrative>Numerator: 49; Denominator: 51.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="97">
            <comment>
              <narrative>Numerator: 64; Denominator: 66.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 32; Denominator: 32.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="97">
            <comment>
              <narrative>Numerator: 64; Denominator: 66.</narrative>
            </comment>
          </target>
          <actual value="97.8">
            <comment>
              <narrative>Numerator: 44; Denominator: 45.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="97">
            <comment>
              <narrative>Numerator: 64; Denominator: 66.</narrative>
            </comment>
          </target>
          <actual value="96.3">
            <comment>
              <narrative>Numerator: 26; Denominator: 27.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="97">
            <comment>
              <narrative>Numerator: 64; Denominator: 66.</narrative>
            </comment>
          </target>
          <actual value="94.1">
            <comment>
              <narrative>Numerator: 32; Denominator: 34.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="97">
            <comment>
              <narrative>Numerator: 64; Denominator: 66.</narrative>
            </comment>
          </target>
          <actual value="96.3">
            <comment>
              <narrative>Numerator: 26; Denominator: 27.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="98.4">
          <comment>
            <narrative>Numerator: 2210; Denominator: 2246.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="99.9">
            <comment>
              <narrative>Numerator: 1384; Denominator: 1386.</narrative>
            </comment>
          </target>
          <actual value="99.9">
            <comment>
              <narrative>Numerator: 946; Denominator: 947.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="99.9">
            <comment>
              <narrative>Numerator: 1384; Denominator: 1386.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 925; Denominator: 925.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="99.7">
            <comment>
              <narrative>Numerator: 1529; Denominator: 1533.</narrative>
            </comment>
          </target>
          <actual value="99.8">
            <comment>
              <narrative>Numerator: 964; Denominator: 966.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="99.7">
            <comment>
              <narrative>Numerator: 1529; Denominator: 1533.</narrative>
            </comment>
          </target>
          <actual value="99.9">
            <comment>
              <narrative>Numerator: 861; Denominator: 862.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="99.8">
            <comment>
              <narrative>Numerator: 1688; Denominator: 1691.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 720; Denominator: 720.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="99.8">
            <comment>
              <narrative>Numerator: 1688; Denominator: 1691.</narrative>
            </comment>
          </target>
          <actual value="99.7">
            <comment>
              <narrative>Numerator: 872; Denominator: 875.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ERI-T-MOH-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Expansion of Stop TB Strategy; Reaching the Hard to Reach and Preventing Missed Opportunities - Eritrea (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Eritrea, Tuberculosis, Ministry of Health of the State of Eritrea</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce TB incidence from 89 per 100,000 population in 2018 to 61.5 per 100,000 population by 2023; Reduce TB mortality from 17.4 per 100,000 population in 2018 to 8.5 per 100,000 population by 2023. Objectives: To increase TB treatment coverage (case detection ratio) from 61% (2018) to 74% and successfully treat at least 93% of DS-TB by 2023; To improve the treatment coverage and management of Drug resistant TB, Childhood TB, TB/HIV and other key populations; To strengthen supportive systems and policies for TB/Leprosy management by 2023; To strengthen evidence-based program monitoring and evaluation; and intensify operational research by 2023.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <other-identifier ref="ERI-T-MOHP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Job Muriuki</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>job.muriuki@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ER" percentage="100">
      <narrative>Eritrea</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="87.71">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="12.29">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="10.87">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="0.57">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.57">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="0.28">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="11.93">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="47.32">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="9afa836c-5fc6-4ff5-973e-19cb5f9bc599" percentage="3.28">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="2.28">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="9.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="70cce1e1-1248-426c-b949-2fe2feec2c0a" percentage="0.56">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key Populations (TB care and prevention) - Children</narrative>
        </description>
      </budget-item>
      <budget-item code="a87c4f51-0287-43c7-9064-8f92833da8c6" percentage="0.83">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="3.92">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="8.58">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">1549840.57</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">1900147.66</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">1824988.77</value>
    </budget>
    <capital-spend percentage="29.09" />
    <transaction ref="263af4c6-6d4e-4607-88ca-44f7f9cef70a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-01-07" />
      <value currency="USD" value-date="2021-01-07">3127424.91</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="dd1466bb-ae9a-4ad1-b94e-10df8d9d86db">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-13" />
      <value currency="USD" value-date="2021-01-13">1278997.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="394c5108-ecc1-433a-bf21-003f171b57c5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-11" />
      <value currency="USD" value-date="2021-06-11">62705.57</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2bd8069-ced4-44c9-897e-3a43ef0053b4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-24" />
      <value currency="USD" value-date="2021-06-24">216697.57</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5d5f0ed2-fad7-45f2-9434-2f72a0dbf588">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-21" />
      <value currency="USD" value-date="2021-07-21">25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="75aca5e6-bd86-4abf-9db8-99ac6d0c6575">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-22" />
      <value currency="USD" value-date="2021-10-22">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a17cd2f2-14c1-4a2b-92d0-56b46780b12f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-24" />
      <value currency="USD" value-date="2022-02-24">25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d2441d2c-2d60-48d9-a223-83824bfd825c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-17" />
      <value currency="USD" value-date="2022-03-17">958977.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="449b7bd0-4768-4876-9397-f7163ac9933d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-24" />
      <value currency="USD" value-date="2022-03-24">215043.82</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ab912cf1-c409-4b40-bb43-c4fba07b57aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-27" />
      <value currency="USD" value-date="2022-06-27">121949.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="03e9a55d-6c03-4084-8682-3497c8c6dbe6">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">3281.47</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a6d4f7cc-d5b5-4a10-973e-3a73cb7172e7">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-3281.47</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="411d72c9-b839-43cf-9ab7-10424b25769f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-02" />
      <value currency="USD" value-date="2022-11-02">1942992.28</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="728764d5-f6d8-4e72-b604-94fca169ac1c">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-11-02" />
      <value currency="USD" value-date="2022-11-02">-273054.95</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="78ecefde-0272-44a1-8034-abaaaea5dfe7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-08" />
      <value currency="USD" value-date="2022-11-08">238028.84</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="48634338-0f5a-479e-8087-84f7b4bb9809">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-21" />
      <value currency="USD" value-date="2023-02-21">1084156.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="95996480-3b21-4c4b-8702-80899bdf64c6">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6c165ad4-a22e-478f-877f-ba8affbcb010">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-11" />
      <value currency="USD" value-date="2023-04-11">206312.48</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="08891442-cb47-4d3f-b293-a7326da4bae4">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d89c879-1a0c-4034-942b-a877be53acbb">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-15" />
      <value currency="USD" value-date="2023-08-15">-414494.96</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f718e92d-6abd-4a97-bf08-21ee45383490">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-15" />
      <value currency="USD" value-date="2023-08-15">744575.78</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="22b20ff8-0097-4002-8c89-cf83c0ddee5d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-17" />
      <value currency="USD" value-date="2023-08-17">162930.78</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="553910a3-4386-48c1-a1b7-7105c7e34f26">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-01" />
      <value currency="USD" value-date="2023-12-01">378067.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c80b22f8-beb1-4913-89eb-a7cb73b64440">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-16" />
      <value currency="USD" value-date="2024-05-16">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3a0c57e9-3959-472b-9100-21920f3e356c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-6615.04</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f361378a-7adc-4fee-88fe-0528654d7d31">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">6615.04</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b0af223d-ccbb-4bbc-b2ab-3f2c1bc4956d">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-125068.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cbee602b-a521-4ba0-9666-a0a8090569ec">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">125068.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c1d94cfe-9845-4b97-aaa8-52acb960bade">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-11" />
      <value currency="USD" value-date="2025-07-11">-203578.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ERI-T-MOHP04-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">1210109.23</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP04, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ERI-T-MOHP04-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">1422845.24</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP04, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ERI-T-MOHP04-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">2277813.71</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP04, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ERI-T-MOHP04-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">7901.65</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP04, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ERI-T-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ERI/2020/Tuberculosis/en/ERI-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2c - Tuberculosis - Eritrea - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR774-ERI-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-06-30" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 17.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 13.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 55.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 12; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3; Denominator: 12; Percentage: 25%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 9; Denominator: 12; Percentage: 75%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 29.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 14; Denominator: 14; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 14; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4; Denominator: 14; Percentage: 28.57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10; Denominator: 14; Percentage: 71.43%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 12; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5; Denominator: 12; Percentage: 41.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 7; Denominator: 12; Percentage: 58.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 12; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2; Denominator: 12; Percentage: 16.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10; Denominator: 12; Percentage: 83.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 64.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26; Denominator: 32.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14; Denominator: 32; Percentage: 43.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 14; Denominator: 14; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 14; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3; Denominator: 14; Percentage: 21.43%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 11; Denominator: 14; Percentage: 78.57%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 17.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 16.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 8.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 13.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 55.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 12; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 9; Denominator: 9; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 29.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 14; Denominator: 14; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 14; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4; Denominator: 14; Percentage: 28.57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10; Denominator: 14; Percentage: 71.43%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 12; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5; Denominator: 12; Percentage: 41.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 7; Denominator: 12; Percentage: 58.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 12; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 2; Denominator: 12; Percentage: 16.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10; Denominator: 12; Percentage: 83.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 64.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 14.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 14; Denominator: 14; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 14; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 3; Denominator: 14; Percentage: 21.43%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 11; Denominator: 14; Percentage: 78.57%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="91.7" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="92" />
          <actual value="90.9">
            <comment>
              <narrative>Numerator: 10; Denominator: 11.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="92" />
          <actual value="88.2">
            <comment>
              <narrative>Numerator: 15; Denominator: 17.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="92" />
          <actual value="83.3">
            <comment>
              <narrative>Numerator: 5; Denominator: 6.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="92" />
          <actual value="94.4">
            <comment>
              <narrative>Numerator: 17; Denominator: 18.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="92" />
          <actual value="89.3">
            <comment>
              <narrative>Numerator: 25; Denominator: 28.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="92" />
          <actual value="80">
            <comment>
              <narrative>Numerator: 8; Denominator: 10.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="94" />
          <actual value="76.9">
            <comment>
              <narrative>Numerator: 20; Denominator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="93" />
          <actual value="71.4">
            <comment>
              <narrative>Numerator: 10; Denominator: 14.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="94" />
          <actual value="83.3">
            <comment>
              <narrative>Numerator: 10; Denominator: 12.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <comment>
            <narrative>Numerator: 152; Denominator: 152.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 152; Denominator: 152.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 152; Denominator: 152.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 152; Denominator: 152.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 152; Denominator: 152.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 152; Denominator: 152.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 152; Denominator: 152.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
          <actual value="1">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 304; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 304; Denominator: 304.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 304; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 304; Denominator: 304.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 304; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 304; Denominator: 304.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 152; Denominator: 152.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1828.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1598.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1598.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1598.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1598.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1598.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1598.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 230.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 230.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 230.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 230.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 230.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 230.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 887.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 822.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 822.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 822.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 822.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 822.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 822.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1006.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1006.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1006.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1006.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1006.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1006.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1753.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1753.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1753.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1753.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1753.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1753.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 3.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 3.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 3.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 3.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 3.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 3.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 72.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 72.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 72.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 72.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 72.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 72.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1095.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 710.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 607.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 103.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 574.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 307.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 403.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 683.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 9.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 18.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2190.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1095.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 893.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 711; Denominator: 893; Percentage: 79.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 182; Denominator: 893; Percentage: 20.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 367; Denominator: 893; Percentage: 41.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 442; Denominator: 893; Percentage: 49.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 451; Denominator: 893; Percentage: 50.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 851; Denominator: 893; Percentage: 95.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 19; Denominator: 893; Percentage: 2.13%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 23; Denominator: 893; Percentage: 2.58%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1188.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 843.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 665; Denominator: 843; Percentage: 78.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 178; Denominator: 843; Percentage: 21.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 372; Denominator: 843; Percentage: 44.13%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 386; Denominator: 843; Percentage: 45.79%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 457; Denominator: 843; Percentage: 54.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 821; Denominator: 841; Percentage: 97.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 2; Denominator: 843; Percentage: 0.24%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 20; Denominator: 841; Percentage: 2.38%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2376.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1957.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1188.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1114.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 870; Denominator: 1114; Percentage: 78.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 244; Denominator: 1114; Percentage: 21.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 389; Denominator: 1114; Percentage: 34.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 429; Denominator: 1114; Percentage: 38.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 685; Denominator: 1114; Percentage: 61.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 889; Denominator: 921; Percentage: 96.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 193; Denominator: 1114; Percentage: 17.32%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 32; Denominator: 921; Percentage: 3.47%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1286.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1038.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 797; Denominator: 1038; Percentage: 76.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 241; Denominator: 1038; Percentage: 23.22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 378; Denominator: 1038; Percentage: 36.42%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 471; Denominator: 1038; Percentage: 45.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 567; Denominator: 1038; Percentage: 54.62%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1006; Denominator: 1035; Percentage: 97.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 3; Denominator: 1038; Percentage: 0.29%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 29; Denominator: 1035; Percentage: 2.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2572.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1286.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1170.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 946; Denominator: 1170; Percentage: 80.85%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 224; Denominator: 1170; Percentage: 19.15%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 477; Denominator: 1170; Percentage: 40.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 418; Denominator: 1170; Percentage: 35.73%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 752; Denominator: 1170; Percentage: 64.27%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1137; Denominator: 1163; Percentage: 97.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 7; Denominator: 1170; Percentage: 0.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 26; Denominator: 1163; Percentage: 2.24%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 155.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 155.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 155.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 155.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 155.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 155.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1826.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3652.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 146.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1826.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 100.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 100; Denominator: 100; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1981.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 51.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 51; Denominator: 51; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3962.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 546.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1981.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 495.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 92.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4290.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5026; Denominator: 2145.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2145.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 820.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 112; Denominator: 820; Percentage: 13.66%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2145.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4206; Denominator: 2145; Percentage: 196.1%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="70" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="76" />
          <actual value="70.6">
            <comment>
              <narrative>Numerator: 1132; Denominator: 1603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="76" />
          <actual value="75.6">
            <comment>
              <narrative>Numerator: 537; Denominator: 710.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="76" />
          <actual value="66.6">
            <comment>
              <narrative>Numerator: 595; Denominator: 893.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="82" />
          <actual value="56.7">
            <comment>
              <narrative>Numerator: 478; Denominator: 843.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="82" />
          <actual value="62.1">
            <comment>
              <narrative>Numerator: 1216; Denominator: 1957.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="82" />
          <actual value="66.2">
            <comment>
              <narrative>Numerator: 738; Denominator: 1114.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="88" />
          <actual value="53.6">
            <comment>
              <narrative>Numerator: 556; Denominator: 1038.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="88" />
          <actual value="64.7">
            <comment>
              <narrative>Numerator: 1429; Denominator: 2208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="88" />
          <actual value="74.6">
            <comment>
              <narrative>Numerator: 873; Denominator: 1170.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="93" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="93.6" />
          <actual value="91.9">
            <comment>
              <narrative>Numerator: 1450; Denominator: 1578.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="93.6" />
          <actual value="92.6">
            <comment>
              <narrative>Numerator: 660; Denominator: 713.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="93.6" />
          <actual value="91.3">
            <comment>
              <narrative>Numerator: 790; Denominator: 865.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="94" />
          <actual value="93.7">
            <comment>
              <narrative>Numerator: 659; Denominator: 703.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="94" />
          <actual value="93.4">
            <comment>
              <narrative>Numerator: 1481; Denominator: 1586.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="94" />
          <actual value="93.1">
            <comment>
              <narrative>Numerator: 822; Denominator: 883.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="94" />
          <actual value="94.2">
            <comment>
              <narrative>Numerator: 1841; Denominator: 1955.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="94" />
          <actual value="93.4">
            <comment>
              <narrative>Numerator: 789; Denominator: 845.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="94" />
          <actual value="94.8">
            <comment>
              <narrative>Numerator: 1052; Denominator: 1110.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="97" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 41; Denominator: 41.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 18; Denominator: 18.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 23; Denominator: 23.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100" />
          <actual value="95">
            <comment>
              <narrative>Numerator: 19; Denominator: 20.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="96.2">
            <comment>
              <narrative>Numerator: 50; Denominator: 52.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="96.9">
            <comment>
              <narrative>Numerator: 31; Denominator: 32.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 29; Denominator: 29.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 55; Denominator: 55.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 26; Denominator: 26.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="99" />
        <baseline year="2019" iso-date="2019-12-31" value="3.94">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 72; Denominator: 1828.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3.94">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 72; Denominator: 1828.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3.94">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 72; Denominator: 1828.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3.94">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 72; Denominator: 1828.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="3.94">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 72; Denominator: 1828.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100" />
          <actual value="98.7">
            <comment>
              <narrative>Numerator: 701; Denominator: 710.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100" />
          <actual value="98.3">
            <comment>
              <narrative>Numerator: 1575; Denominator: 1603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100" />
          <actual value="97.9">
            <comment>
              <narrative>Numerator: 874; Denominator: 893.</narrative>
            </comment>
          </actual>
          <actual value="2.58">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 23; Denominator: 893.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="90">
            <comment>
              <narrative>Numerator: 1762; Denominator: 1957.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100" />
          <actual value="99.8">
            <comment>
              <narrative>Numerator: 841; Denominator: 843.</narrative>
            </comment>
          </actual>
          <actual value="2.38">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 20; Denominator: 841.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100" />
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 921; Denominator: 1114.</narrative>
            </comment>
          </actual>
          <actual value="3.47">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 32; Denominator: 921.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100" />
          <actual value="99.7">
            <comment>
              <narrative>Numerator: 1035; Denominator: 1038.</narrative>
            </comment>
          </actual>
          <actual value="2.79">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 29; Denominator: 1038.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="99.5">
            <comment>
              <narrative>Numerator: 2198; Denominator: 2208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100" />
          <actual value="99.4">
            <comment>
              <narrative>Numerator: 1163; Denominator: 1170.</narrative>
            </comment>
          </actual>
          <actual value="2.24">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 26; Denominator: 1163.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ERI-T-MOH-5</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Expansion Of Stop TB Strategy; Reaching The Hard To Reach And Preventing Missed Opportunities - Eritrea (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Eritrea, Tuberculosis, Ministry of Health of the State of Eritrea</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce TB incidence from 74 per 100,000 population in 2022 to 45 per 100,000 population by 2026; Reduce TB mortality from 14 per 100,000 population in 2022 to 4 per 100,000 population by 2026. Objectives: To increase TB treatment coverage (case detection ratio) from 60% (2022) to 85% and successfully treat at least 95% of DS-TB by 2026; To improve the treatment coverage and management of Drug resistant TB, Childhood TB, TB/HIV and other key populations; To strengthen supportive systems and policies for TB management; To strengthen evidence-based program monitoring and evaluation; and intensify operational research.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the State of Eritrea</narrative>
    </participating-org>
    <other-identifier ref="ERI-T-MOHP05" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Job Muriuki</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>job.muriuki@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ER" percentage="100">
      <narrative>Eritrea</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="77.92">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="22.08">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="9.64">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="0.61">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2eb956de-b42d-4ae1-b0a8-8ac53c3bbb5a" percentage="10.19">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Community health workers: contracting, remuneration and retention</narrative>
        </description>
      </budget-item>
      <budget-item code="57ef74d8-840a-4792-b7d8-0c12163d7d91" percentage="0.85">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Biosafety and biosecurity, infrastructure and equipment</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.46">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="cb85db5b-1f59-4c7a-ba74-2cb30ee6a84b" percentage="0.33">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Operational Research</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.81">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="3.75">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="6.6">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="6.84">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="1.92">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="31.72">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="14.13">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="2.61">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="8.81">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0.27">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.05">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="0.41">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">1067263.24</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">1814509.31</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">1593922.49</value>
    </budget>
    <capital-spend percentage="12.13" />
    <transaction ref="a7692a25-4dce-4f62-af5a-05ce15bc56a5">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-18" />
      <value currency="USD" value-date="2023-12-18">2475562.78</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c1c878f4-eb7d-49fd-89af-a775a0781b4c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-12-20" />
      <value currency="USD" value-date="2023-12-20">476859.38</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="43aef7cf-e175-4db5-98dc-76f29888d350">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-04" />
      <value currency="USD" value-date="2024-06-04">409778.53</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ede6296d-3de3-4ef4-9f1d-653844421efd">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-04" />
      <value currency="USD" value-date="2024-06-04">311836.38</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="61bf8110-a408-4ee0-9c9b-c81ba60353f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-17" />
      <value currency="USD" value-date="2024-12-17">401978.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fb3013f3-5f0a-497f-b3e8-9f52ef2cc578">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-01" />
      <value currency="USD" value-date="2025-03-01">22964.71</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e9c3975a-cfb9-4fba-8902-ada9e7ba2a1b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-22964.71</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d5c30d9a-289f-4715-86d9-0ae79f65d1a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-17" />
      <value currency="USD" value-date="2025-04-17">279669.50</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="20393af5-a65b-4554-ad96-8cdafbda6207">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-17" />
      <value currency="USD" value-date="2025-06-17">417741.62</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="960f711c-3e05-4638-836a-6bb2dbfe63b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">125068.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a743b77-9fb6-44b4-8800-68db11cf19a6">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">125068.00</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="47af9c80-1c62-49ed-b5f0-ea2c47233aef">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-22" />
      <value currency="USD" value-date="2026-01-22">-177699.37</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="76dca483-a80c-4e35-a1b1-258ce4e05864">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-22" />
      <value currency="USD" value-date="2026-01-22">1720913.00</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5865efa2-710d-4db9-90df-f39cabc441be">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-27" />
      <value currency="USD" value-date="2026-01-27">344729.32</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d522f95b-2be5-4b45-83d1-1a670cb6fe44">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-27" />
      <value currency="USD" value-date="2026-01-27">660990.55</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3dc25ab9-63fb-4cc9-bd24-3e137b1e7dd6">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-01" />
      <value currency="USD" value-date="2026-03-01">43969.56</value>
      <description>
        <narrative>Funds returned to the Global Fund from ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="19743125-0368-4203-9129-df1af397f8d3">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-12" />
      <value currency="USD" value-date="2026-03-12">-43969.56</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="784856a2-1773-432b-80dc-c26750b6bd8f">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-22" />
      <value currency="USD" value-date="2026-05-22">-715193.13</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b48e5f40-1eb9-4c23-ba80-956ea69656ad">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-22" />
      <value currency="USD" value-date="2026-05-22">912033.01</value>
      <description>
        <narrative>Global Fund commitment to ERI-T-MOHP05.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f81f8122-84a4-45c0-bb87-dccd60f4c313">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-26" />
      <value currency="USD" value-date="2026-05-26">12972.51</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="24571223-ae1e-4a65-9e9b-6339fa9d4ae0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-06-16" />
      <value currency="USD" value-date="2026-06-16">114290.50</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e41fb666-c9bf-43e1-85d4-b911e4a40f81">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">162372.11</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="db0335ab-3d67-4f06-b89f-ac01354dde3c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-25" />
      <value currency="USD" value-date="2026-08-25">359261.25</value>
      <description>
        <narrative>Global Fund disbursement to ERI-T-MOHP05 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ERI-T-MOHP05-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">1068474.88</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP05, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ERI-T-MOHP05-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">960725.82</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the State of Eritrea for ERI-T-MOHP05, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the State of Eritrea</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ERI-T-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ERI/2023/Tuberculosis/en/ERI-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 2 - Tuberculosis - Eritrea - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1566-ERI-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-05-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 795,458.00 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.3(1)(a) and 6.3(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall submit a revised commitment letter within 6 months of the Implementation Period start date that: (a) fulfils an indicative total minimum co-financing commitment of approximately USD 132,500,000.00 in investments in overall government health expenditure/Resilient and Sustainable Systems for Health (RSSH), with the final amount subject to further agreement between the Global Fund and the Grantee, from 2024-2026 (inclusive); and (b) fulfils the programmatic commitments linked to overall RSSH and PHC strengthening with a minimum commitment to a total expenditure of USD 18,183,000 on the following budget lines for 2024-2026: i) “Clinics and Health Centers”; ii) “Health Sciences Institutes”; and iii) “National Health Laboratories". If appropriate, the required increase in expenditure against the above budget lines may be contributed by any other specific and monitorable recurrent or development budget items (such as community hospitals) or deliverables that may be agreed with the Global Fund. (3) The Grantee shall provide to the Global Fund, by no later than 31 March of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: (a) evidence of approved health budgets for the upcoming year; and (b) total health expenditure and reports in the previous fiscal year. (3) The Grantee shall provide to the Global Fund a methodology and plan to track approved budgets and reported expenditures relating to Global Fund supported programs (sections 2(a) and 2(b) above) within 6 months of the Implementation Period start date. The plan should outline the roles and responsibilities of all stakeholders involved.</narrative>
      </condition>
      <condition type="2">
        <narrative>4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 26.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 26.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 26.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 9.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 17.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 17.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 24.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 2.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 2.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 55.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 6.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 6.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 27.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 54.5.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 26; Denominator: 26; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 26; Denominator: 26; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 26; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 26; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 9; Denominator: 26; Percentage: 34.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 9; Denominator: 26; Percentage: 34.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 26; Denominator: 26; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 26; Denominator: 26; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 17; Denominator: 26; Percentage: 65.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 17; Denominator: 26; Percentage: 65.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 0; Denominator: 26; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 0; Denominator: 26; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5; Denominator: 5; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 12; Denominator: 12; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 6; Denominator: 12; Percentage: 50%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 6; Denominator: 12; Percentage: 50%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17; Denominator: 17; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9; Denominator: 9; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 17; Denominator: 17; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 5; Denominator: 17; Percentage: 29.41%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 12; Denominator: 17; Percentage: 70.59%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Percentage: 89.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 25; Denominator: 28; Percentage: 89.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 25; Denominator: 28; Percentage: 89.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 22; Denominator: 25; Percentage: 88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 22; Denominator: 25; Percentage: 88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 0; Denominator: 28; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 0; Denominator: 28; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95.65%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21; Denominator: 26; Percentage: 80.77%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95.65%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10; Denominator: 12; Percentage: 83.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 21.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 21; Denominator: 21; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0; Denominator: 21.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 96.15%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 96.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 22; Denominator: 26; Percentage: 84.62%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 96.15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12; Denominator: 14; Percentage: 85.71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 22; Denominator: 22; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0; Denominator: 22; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 95.65%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 95.45%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="301" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="348" />
          <actual value="146" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="174" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="174" />
          <actual value="75" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="390" />
          <actual value="112" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="195" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="195" />
          <actual value="47" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="218" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="218" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="20" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="22" />
          <actual value="60" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="11" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="11" />
          <actual value="43" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of community health workers remunerated on time and in-full (as per their contract) every month during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Human resources for health (HRH) and quality of care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of community health workers remunerated on time and in-full (as per their contract) every month during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 600; Denominator: 600.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 600; Denominator: 600.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 1200; Denominator: 1200.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 600; Denominator: 600.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 600; Denominator: 600.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 600; Denominator: 600.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="100">
          <comment>
            <narrative>Numerator: 79; Denominator: 79.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 79; Denominator: 79.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 79; Denominator: 79.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 80; Denominator: 80.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 79; Denominator: 79.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 80; Denominator: 80.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 79; Denominator: 79.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 79; Denominator: 79.</narrative>
            </comment>
          </target>
          <actual value="95">
            <comment>
              <narrative>Numerator: 76; Denominator: 80.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 79; Denominator: 79.</narrative>
            </comment>
          </target>
          <actual value="95">
            <comment>
              <narrative>Numerator: 76; Denominator: 80.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 316; Denominator: 316; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 316; Denominator: 316; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 316; Denominator: 316; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 316; Denominator: 316; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 316; Denominator: 316; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 316; Denominator: 316; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 304; Denominator: 304; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 158; Denominator: 158; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 158; Denominator: 158; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 152; Denominator: 152; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 304.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 304.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 316; Denominator: 316; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 160; Denominator: 160; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 158; Denominator: 158; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 158; Denominator: 158; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 80; Denominator: 80; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 160; Denominator: 160; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 160; Denominator: 160; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="1963" />
        <baseline year="2022" iso-date="2022-12-31" value="1541">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1541">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="422">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="422">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="764">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="764">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="816">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="816">
          <dimension name="Gender" value="Female" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1147">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1147">
          <dimension name="Gender" value="Male" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1753">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="1753">
          <dimension name="HIV status" value="Negative" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="53">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="53">
          <dimension name="HIV status" value="Positive" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="195">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="195">
          <dimension name="HIV status" value="Unknown" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="2169" />
          <actual value="1744" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="1084" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1085" />
          <actual value="870" />
          <actual value="1372">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="372">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="666">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="817">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="927">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="1694">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="41">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="9">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="1028" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2056" />
          <actual value="2050" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="1028" />
          <actual value="916" />
          <actual value="1590">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="460">
            <dimension name="Age" value="&lt;15" />
          </actual>
          <actual value="709">
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
          </actual>
          <actual value="869">
            <dimension name="Gender" value="Female" />
          </actual>
          <actual value="1181">
            <dimension name="Gender" value="Male" />
          </actual>
          <actual value="1991">
            <dimension name="HIV status" value="Negative" />
          </actual>
          <actual value="32">
            <dimension name="HIV status" value="Positive" />
          </actual>
          <actual value="27">
            <dimension name="HIV status" value="Unknown" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="923" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="923" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Percentage: 63.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 1216; Denominator: 1963; Percentage: 61.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 1216; Denominator: 1963; Percentage: 61.95%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1041; Denominator: 1744; Percentage: 59.69%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 69.95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 69.95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 503; Denominator: 870; Percentage: 57.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 1041.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 75.07%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 75.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1206; Denominator: 2050; Percentage: 58.83%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 75.07%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 570; Denominator: 916; Percentage: 62.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 1206.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 85.03%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 85.03%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="2.29">
          <comment>
            <narrative>Numerator: 45; Denominator: 1963.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="3">
            <comment>
              <narrative>Numerator: 65; Denominator: 2170.</narrative>
            </comment>
          </target>
          <actual value="2.35">
            <comment>
              <narrative>Numerator: 41; Denominator: 1744.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="2.95">
            <comment>
              <narrative>Numerator: 32; Denominator: 1085.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="3.04">
            <comment>
              <narrative>Numerator: 33; Denominator: 1085.</narrative>
            </comment>
          </target>
          <actual value="2.41">
            <comment>
              <narrative>Numerator: 21; Denominator: 870.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="4.01">
            <comment>
              <narrative>Numerator: 46; Denominator: 1147.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="4">
            <comment>
              <narrative>Numerator: 92; Denominator: 2294.</narrative>
            </comment>
          </target>
          <actual value="1.02">
            <comment>
              <narrative>Numerator: 21; Denominator: 2050.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="4.01">
            <comment>
              <narrative>Numerator: 46; Denominator: 1147.</narrative>
            </comment>
          </target>
          <actual value="0.66">
            <comment>
              <narrative>Numerator: 6; Denominator: 916.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="4.98">
            <comment>
              <narrative>Numerator: 61; Denominator: 1226.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="5.06">
            <comment>
              <narrative>Numerator: 62; Denominator: 1226.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT-other 1 Number of female patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>TBDT-other 1 Number of female patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 816.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 455.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 911.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 817.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 456.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 400.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 482.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 964.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 869; Denominator: 2050; Percentage: 42.39%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 482.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 426; Denominator: 916; Percentage: 46.51%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 520.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 520.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="93.38" />
        <baseline year="2022" iso-date="2022-12-31" value="95">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 38; Denominator: 40.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="95">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 38; Denominator: 40.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="94.97" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95" />
          <actual value="93.44">
            <comment>
              <narrative>Numerator: 2065; Denominator: 2210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="94.97" />
          <actual value="93.84">
            <comment>
              <narrative>Numerator: 1096; Denominator: 1168.</narrative>
            </comment>
          </actual>
          <actual value="92.73">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 51; Denominator: 55.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="96" />
          <actual value="93.57">
            <comment>
              <narrative>Numerator: 1631; Denominator: 1743.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="95.99" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95.99" />
          <actual value="93.03">
            <comment>
              <narrative>Numerator: 814; Denominator: 875.</narrative>
            </comment>
          </actual>
          <actual value="87.5">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 35; Denominator: 40.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95.99" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95.99" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="510" />
        <baseline year="2022" iso-date="2022-12-31" value="297">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="297">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="117">
          <dimension name="Age" value="5-14" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="117">
          <dimension name="Age" value="5-14" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="96">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="96">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="510">
          <dimension name="Provider type" value="Public" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="510">
          <dimension name="Provider type" value="Public" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="3452" />
          <actual value="1501" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="1726" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1726" />
          <actual value="810" />
          <actual value="867">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="428">
            <dimension name="Age" value="5-14" />
          </actual>
          <actual value="206">
            <dimension name="Age" value="&lt;5" />
          </actual>
          <actual value="1501">
            <dimension name="Provider type" value="Public" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="2216" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="4432" />
          <actual value="1572" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2216" />
          <actual value="801" />
          <actual value="874">
            <dimension name="Age" value="15+" />
          </actual>
          <actual value="491">
            <dimension name="Age" value="5-14" />
          </actual>
          <actual value="207">
            <dimension name="Age" value="&lt;5" />
          </actual>
          <actual value="1572">
            <dimension name="Provider type" value="Public" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="2675" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="2675" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="96.23" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 41; Denominator: 41.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 22; Denominator: 22.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 32; Denominator: 32.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100" />
          <actual value="100">
            <comment>
              <narrative>Numerator: 14; Denominator: 14.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Percentage: 90.07%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 53; Denominator: 1768; Percentage: 3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 53; Denominator: 1768; Percentage: 3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 195; Denominator: 1963; Percentage: 9.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 195; Denominator: 1963; Percentage: 9.93%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1735; Denominator: 1744; Percentage: 99.48%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 862; Denominator: 870; Percentage: 99.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 41.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 9.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2023; Denominator: 2050; Percentage: 98.68%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 902; Denominator: 916; Percentage: 98.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>